Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA issues complete response letter for Sandoz rituximab biosimilar

May 3, 2018

BIIB-092 shows safe pharmacodynamic activity in progressive supranuclear palsy trial

May 3, 2018

WHO grants INN seliforant to Sensorion's SENS-111

May 3, 2018

Phase I data on CD34+ therapy presented for retinal degeneration

May 3, 2018

FDA advisory committee votes on Achaogen's plazomicin for cUTI and bloodstream infections

May 3, 2018

Microrod formulation of travoprost provides sustained release

May 3, 2018

Arixa completes seed financing to advance oral avibactam prodrug ARX-1796

May 3, 2018

FDA grants fast track designation to RGX-121 gene therapy

May 3, 2018

Hanmi opens first-in-human trial of HM-15211 in healthy obese subjects

May 3, 2018

Lycera updates on ROR-gamma agonists LYC-54143 and LYC-55716

May 3, 2018

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...